Shah Capital pushes for Novavax (NVAX) sale

Shah Capital is urging Novavax (NASDAQ: NVAX) board to pursue a sale, according to a Reuters report on Tuesday.

• The fund is citing a third consecutive year of poor roll-out of its COVID-19 shot.
• Shah Capital owns a 7.2% stake in the company and is the second largest shareholders.

You May Also Be Interested In

• PayPal on watch amid layoffs rumors
• Titan Machinery (TITN) 2K contracts of September 22.50 calls trade, share price up 17%
• Baxter (BAX) spreader of 2500 contracts of September 24.50 and 25.50 puts